Please register to participate in our discussions with 2 million other members - it's free and quick! Some forums can only be seen by registered members. After you create your account, you'll be able to customize options and access all our 15,000 new posts/day with fewer ads.
Again patents are not limited by citizenship. And will not be.
I never discussed anyone's citizenship.
Quote:
The patents were not on US funded development. They are on improvements to the device. And the US may well contract with a private developer for a capability while the IP rights stay with the developer. The US may require the right to use those IP rights but not always. Some developers will not do the development if not retaining the rights. A matter of the contract actually negotiated.
Think about it. If you have personal expertise or a team specializing in an area are you going to give away the work product because you use those skills to develop a particular gizmo for the US. Not going to happen if the developer is actually dominant in an area.
Those willing to develop a $1 item to sell for $50 would be nearly unlimited.
While you may want to dwell on the fact that the CEOs dad is a democrat. the company itself is American and employs 35000 people and is an example of the free market system in action with its outlandish price increase of its Epipen.Perhaps government should step in socialist style and tell Mylan what prices it should sell its products for?
You completely missed the sarcasm used to illustrate the hypocrisy.
Last edited by Mack Knife; 08-27-2016 at 08:39 PM..
You do not understand patents. They go to individuals not corporations .
There are vast numbers of things that cost little and sell for a lot. Advice is high on the list. .
Quote:
Originally Posted by pknopp
At best, far, far, far too simplistic. Just to keep it simple. Are you saying a corporation can't buy a patent and hence then own it?
Which wasn't the point was it?
Listen guys, both of you are making great points & all but when Mr. Trump becomes President, none of this will even matter.
Quote:
..."When it comes time to negotiate the cost of drugs, we are going to negotiate like crazy,†Mr. Trump told a crowd of several hundred people gathered at a town hall-style campaign event here. ...
To follow through with the pledge, Mr. Trump would likely have to convince Congress to grant him the authority — Medicare is at present barred by law from negotiating lower prescription prices with pharmaceutical manufacturers. Bills have been introduced in recent years to allow the government to negotiate for Medicare Part D prescription plans, but none have gained traction in Congress.. ...
At best, far, far, far too simplistic. Just to keep it simple. Are you saying a corporation can't buy a patent and hence then own it?
Which wasn't the point was it?
The patents go to individuals. They can be assigned to anything. But they are not granted to corporations. So you want to limit the right of the individual receiving a patent to assign it as he or she sees fit?
You are out of your depth.
Medical devices should be regulated. That includes the prices charged. Free market and medicine are not compatible.
The patents go to individuals. They can be assigned to anything. But they are not granted to corporations. So you want to limit the right of the individual receiving a patent to assign it as he or she sees fit?
You didn't answer my question so there is really no need to continue.
The patents go to individuals. They can be assigned to anything. But they are not granted to corporations. So you want to limit the right of the individual receiving a patent to assign it as he or she sees fit?
You are out of your depth.
Medical devices should be regulated. That includes the prices charged. Free market and medicine are not compatible.
Senator Amy Klobuchar sponsored, along with 6 D & 2 I co-sponsors, no real traction though:
Medicare Prescription Drug Price Negotiation Act of 2015
Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to direct the Secretary of Health and Human Services to negotiate with pharmaceutical manufacturers the prices that may be charged to Medicare part D prescription drug plan (PDP) sponsors and MedicareAdvantage (MA) organizations for covered part D drugs for part D eligible individuals who are enrolled under a PDP or under an MA-Prescription Drug plan.
Please register to post and access all features of our very popular forum. It is free and quick. Over $68,000 in prizes has already been given out to active posters on our forum. Additional giveaways are planned.
Detailed information about all U.S. cities, counties, and zip codes on our site: City-data.com.